Disclosure is part of the structure
Promoter pledges in listed companies are disclosable, and the market reads them. Facility size, tenor and the visibility of the repayment source should all be considered against how the disclosure will be interpreted by institutional shareholders and analysts.
Cover ratios and the spiral risk
Facilities are sized to a security cover multiple rather than a simple loan-to-value, with a top-up trigger and an invocation threshold. The failure mode is well known: a price fall triggers a top-up, an invocation follows, the invocation itself pressures the price.
Structural defences are negotiated up front — conservative initial cover, a meaningful cure period, a cap on the lender's right to sell in any single session, and the ability to substitute collateral instead of paying cash.
- Initial cover set with deliberate headroom, not at the lender's minimum
- Cure period long enough to arrange a top-up from a real source
- Restrictions on the lender's pace of sale on invocation
- Right to substitute other collateral in place of cash top-up
End-use and lender type
End-use restrictions differ sharply by lender category, and are the reason a mandate goes to one desk rather than another. Personal liquidity, an acquisition of further shares, and refinancing an existing pledge are each treated differently. Establishing permitted end-use before approaching lenders avoids a late and expensive restructure.
Common questions
Is a promoter share pledge required to be disclosed?
Yes, promoter pledges in listed companies are disclosable and are closely read by institutional shareholders. Facility size and tenor should be structured with that disclosure in mind.
How is promoter funding sized?
Against a security cover multiple rather than a simple loan-to-value, with a defined top-up trigger and invocation threshold. Setting initial cover with deliberate headroom is the main defence against a forced-sale spiral.
Can promoter funding be used to buy more shares?
End-use restrictions vary sharply by lender category. Personal liquidity, acquisition of further shares and refinancing an existing pledge are treated differently, so permitted end-use should be settled before lenders are approached.
Every facility described here is arranged case by case, across our full range of mandates and using the desk process. A first conversation is confidential and carries no obligation.
Request a consultation